Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease.

ABSTRACT:

SUBMITTER: Lu J 

PROVIDER: S-EPMC11344091 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature